Darian T. Carroll

Darian T. Carroll

Auto-generated profile, based on publicly available information

Darian T. Carroll

Howard Hughes Medical Institute

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 October 2021 in Molecular Metabolism
Verified
Journal Article
Open access
KBKarin J. Bosma
Karin J. Bosma
SASpencer R. Andrei
Spencer R. Andrei
LKLiora S Katz
Liora S Katz
ASAshley A. Smith
Ashley A. Smith
JDJennifer C. Dunn
Jennifer C. Dunn
MGMaureen A Gannon
Maureen A Gannon
Type 2 diabetes is characterized by hyperglycemia and inflammation. Prostaglandin E2, which signals through four G protein-coupled receptors (EP1-4), is a mediator of inflammation and is upregulated in diabetes. We have shown previously that EP3 receptor blockade promotes β-cell proliferation and survival in isolated mouse and human islets ex vivo. Here, we analyzed whether systemic EP3 blockade could enhance β-cell mass and identity in the setting of type 2 diabetes using mice with a spontaneous mutation in the leptin receptor (Leprdb). Four- or six-week-old, db/+, and db/db male mice were treated with an EP3 antagonist daily for two weeks. Pancreata were analyzed for α-cell and β-cell proliferation and β-cell mass. Islets were isolated for transcriptomic analysis. Selected gene expression changes were validated by immunolabeling of the pancreatic tissue sections. EP3 blockade increased β-cell mass in db/db mice through enhanced β-cell proliferation. Importantly, there were no effects on α-cell proliferation. EP3 blockade reversed the changes in islet gene expression associated with the db/db phenotype and restored the islet architecture. Expression of the GLP-1 receptor was slightly increased by EP3 antagonist treatment in db/db mice. In addition, the transcription factor nuclear factor E2-related factor 2 (Nrf2) and downstream targets were increased in islets from db/db mice in response to treatment with an EP3 antagonist. The markers of oxidative stress were decreased. The current study suggests that EP3 blockade promotes β-cell mass expansion in db/db mice. The beneficial effects of EP3 blockade may be mediated through Nrf2, which has recently emerged as a key mediator in the protection against cellular oxidative damage.

1 June 2023 in American Journal of Physiology-Endocrinology and Metabolism
Verified
Journal Article
Closed access
DCDarian T. Carroll
Darian T. Carroll
JEJoseph M. Elsakr
Joseph M. Elsakr
AMAllie Miller
Allie Miller
JFJennifer Fuhr
Jennifer Fuhr
SLSarah Rene Lindsley
Sarah Rene Lindsley
MGMaureen A Gannon
Maureen A Gannon
Programed adaptations in islets in response to maternal WSD exposure may alter β-cell response to metabolic stress in offspring. We show that islets from maternal WSD-exposed offspring hypersecrete insulin, possibly due to increased components of stimulus-secretion coupling. These findings suggest that islet hyperfunction is programed by maternal diet, and changes can be detected as early as the postweaning period in nonhuman primate offspring.

12 August 2026
Verified
Preprint
Open access
PDF file
WPWorking Group Participants
Working Group Participants
TATony Alves
Tony Alves
FAFemi Qudus Arogundade
Femi Qudus Arogundade
LCLeyla Cabugos
Leyla Cabugos
DCDarian Carroll
Darian Carroll
RCRowan Cockett
Rowan Cockett
Between January and July 2026, the Continuous Science Foundation (CSF) , PREreview , and more than 60 researchers, infrastructure builders, publishers, and community members came together as the Modular Peer Review Working Group . Together, we explored a simple but important question: What might peer review look like if it evolved alongside the research process, rather than centering only on the final paper?